Amniotic fluid and plasma concentrations of pregnancy-associated plasma protein-A (PAPP-A) throughout pregnancy: comparison with other fetoplacental products |
| |
| Authors: | P BISCHOF Research Biochemist S DUBERG Research Fellow W HERRMANN Chairman of Obstetrics and Gynaecology P C SIZONENKO Professor of Biology of Growth and Reproduction Clinical Biology of Growth and Reproduction |
| |
| Institution: | Department of Obstetrics and Gynaecology, Universitéde Genève, Maternité, 1211 Genève 4, Switzerland |
| |
| Abstract: | Summary. The development of a sensitive radioimmunoassay has enabled measurements of pregnancy-associated plasma protein-A (PAPP-A) to be performed from early pregnancy. The present paper compares the plasma concentrations of PAPP-A with the levels of two trophoblastic proteins, human placental lactogen (hPL) and the β-subunit of human chorionic gonadotrophin (β-hCG), with a steroid of fetoplacental origin, total oestriol (total E3), and with a fetal protein, α-fetoprotein (AFP). PAPP-A was also measured in amniotic fluid and in maternal urine. In contrast with the secretion of the other substances studied, which either reach a plateau or even decrease during the last 4 weeks of pregnancy, PAPP-A steadily increased in the maternal circulation from 7 to 40 weeks gestation. It is proposed that PAPP-A production is either not related to placental mass or that PAPP-A is not of trophoblastic origin. The increase of PAPP-A in amniotic fluids parallels the increase in maternal blood; virtually no PAPP-A is excreted in urine. |
| |
| Keywords: | |
|
|
